USPTO serial 79383213
THERALUGAND
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- TWOHIG, SHANNON MARIE
- Law office
- TMO LAW OFFICE 121
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with THERALUGAND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ursula B. Day
Ursula B. Day law firm of Ursula B. Day35 west 35th streetSuite 900new york, NY 10001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; radioactive elements for scientific purposes; detergents for use in manufacture of radioactive substances; salts for industrial purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; isotopes for industrial purposes; chemical reagents other than for medical or veterinary purposes; salts being chemical preparations, namely, industrial salts; fissionable chemical elements, namely, radioactive elements for scientific purposes; emollients for industrial purposes; enzymes for scientific purposes; dyes for scientific or research purposes; glycoprotein; immunoglobulins, being biological preparations for scientific use, other than for medical use; immunoassay reagents for scientific purposes, other than for medical use; immunological antibodies for scientific purposes, other than for medical use; biomolecule labeling kits comprising reagents for use in scientific research; laboratory reagents for scientific use; tagged antibodies for scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; proteins in raw form for use in science; proteins in raw form for scientific purposes for binding antibodies other than for medical use; reagents for scientific purposes; substances for scientific use, namely, radioactive substances; universal reagents for automated test systems for scientific purposes; diagnostic reagents for scientific or research use | ACTIVE | — |
| 005 | Medical and veterinary preparations, namely, radioactive preparations for use in treating cancer; biological reagents for medical use; biological reagents for veterinary use; diagnostic chemical reagents for medical use; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; clinical medical reagents; diagnostic reagents for medical use; clinical diagnostic reagents for medical or veterinary purposes; reagents for use in diagnostic pregnancy tests for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for microbiological analysis for medical purposes; mineral salts for medical purposes; chemical preparations for medical purposes, namely, for treatment of hormonal imbalances; chemical preparations for pharmaceutical purposes, namely, for treatment of migraines; chemical preparations for veterinary purposes, namely, chemical reagents for veterinary use; chemico-pharmaceutical preparations for the treatment of gout; disinfectants; diagnostic preparations for medical use; pharmaceutical, veterinary and sanitary preparations for treatment of tumor diseases; radioactive substances for medical purposes | ACTIVE | — |
| 042 | Science and technology services, namely, scientific research services; testing, authentication and quality control, namely, testing of pharmaceuticals, quality control for others; bacteriological consultation and research; consultancy in the field of pharmaceutical research; consultancy relating to laboratory testing of materials; biological research, clinical research in the field of chemotherapy and medical research; medical research laboratory services; analysis of human serum for medical research; research and development in the pharmaceutical and biotechnology fields; medical research laboratory services relating to the production of monoclonal antibodies; research and development services in the field of antibodies; pharmaceutical research and development; consultancy relating to biotechnology; biochemical analysis; biochemistry research services; biological research; microbiological testing; preparation of scientific research reports in the biotechnology field; research and development services in the field of immunology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Eckert & Ziegler Radiopharma GmbH
- Other trademarks owned by Eckert & Ziegler Radiopharma GmbH
- Other trademarks owned by Eckert & Ziegler Radiopharma GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named THERALUGAND
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 31, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 31, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 3, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 18, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 29, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 9, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 16, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 16, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 16, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 12, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 12, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 12, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 24, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 3, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 2, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 14, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |